This research proposes a molecular design pipeline that integrates deep generative models, graph neural networks, and multi-objective reinforcement learning to optimize pharmaceutical compounds. The framework aims to reduce drug discovery timelines by balancing drug-likeness, synthetic accessibility, target affinity, and safety profiles through Pareto-optimal multi-objective optimization.
Key findings
Proposes a comprehensive molecular design pipeline integrating deep generative models and multi-objective optimization.
Introduces a novel reward shaping mechanism for balancing multiple competing objectives in drug design.
Includes rigorous benchmarking protocols and evaluation metrics for molecular validity and therapeutic potential.
Plans detailed experiments including ablation studies and comparison with existing methods.
Limitations & open questions
Potential failure modes include scaffold bias, reward hacking, and distributional shifts.